Thanks Parto yes that looks correct I didn't reflect back on the statement . Do I still read correctly that on average with no group 40/80 or placebo has the disease progressed (by this measure) at all over the two years . ? At worst for all on average has halted but with 80 cohort on average has improved. This would be versus a statistically expected average deterioration or progression of +2 ( I think ) every 6 months.
Ann: NTCELL Parkinsons trial 2 year data analysis shows success, page-62
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $1.4K | 199.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 6404404 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1428102 | 2 |
View Market Depth
| Last trade - 11.17am 11/10/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |